Rating History for ABIOMED (ABMD) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for ABMD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/2/2022 David Lewis Upgrade Equalweight
(Underweight)		 380.00
(235.00)		 377.82
(381.02)		 0.85% Details